Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 3
2007 1
2008 1
2011 1
2012 2
2015 4
2016 2
2017 4
2018 2
2019 2
2020 2
2021 2
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D, Dziedzic R, Drynda A, Gradzikiewicz A, Jakieła B, Celińska-Löwenhoff M, Padjas A, Matyja-Bednarczyk A, Zaręba L, Bazan-Socha S. Mizera D, et al. Among authors: celinska lowenhoff m. Front Immunol. 2023 Oct 12;14:1275892. doi: 10.3389/fimmu.2023.1275892. eCollection 2023. Front Immunol. 2023. PMID: 37901210 Free PMC article.
Thrombin generation potential is increased in patients with autoimmune inflammatory myopathies.
Kuszmiersz P, Siwiec-Koźlik A, Pacholczak-Madej R, Rams A, Celińska-Lowenhoff M, Iwaniec T, Kosałka-Węgiel J, Zaręba L, Dziedzic R, Bazan-Socha S, Dropiński J. Kuszmiersz P, et al. Among authors: celinska lowenhoff m. Adv Med Sci. 2022 Sep;67(2):346-352. doi: 10.1016/j.advms.2022.08.005. Epub 2022 Sep 6. Adv Med Sci. 2022. PMID: 36084366
Chronic prothrombotic tendency in patients with granulomatosis with polyangiitis.
Iwaniec T, Celińska-Löwenhoff M, Zaręba L, Ząbczyk M, Wawrzycka-Adamczyk K, Kosałka-Węgiel J, Wójcik K, Musiał J. Iwaniec T, et al. Among authors: celinska lowenhoff m. Pol Arch Intern Med. 2021 Aug 30;131(7-8):666-672. doi: 10.20452/pamw.16027. Epub 2021 Jun 8. Pol Arch Intern Med. 2021. PMID: 34100569 Free article.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. Bala MM, et al. Among authors: celinska lowenhoff m. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD012169. doi: 10.1002/14651858.CD012169.pub2. Cochrane Database Syst Rev. 2017. PMID: 28968483 Free PMC article. Updated. Review.
Increased Oxidative Stress in Asthma-Relation to Inflammatory Blood and Lung Biomarkers and Airway Remodeling Indices.
Bazan-Socha S, Wójcik K, Olchawa M, Sarna T, Pięta J, Jakieła B, Soja J, Okoń K, Zarychta J, Zaręba L, Stojak M, Potaczek DP, Bazan JG, Celińska-Lowenhoff M. Bazan-Socha S, et al. Among authors: celinska lowenhoff m. Biomedicines. 2022 Jun 24;10(7):1499. doi: 10.3390/biomedicines10071499. Biomedicines. 2022. PMID: 35884804 Free PMC article.
36 results